Noxa upregulation is associated with apoptosis of chronic lymphocytic leukemia cells induced by hyperforin but not flavopiridol

被引:10
|
作者
Zaher, M. [1 ]
Akrout, I.
Mirshahi, M.
Kolb, J-P
Billard, C.
机构
[1] INSERM, Equipe 18, UMRS 872, Ctr Rech Cordeliers, Paris, France
关键词
INHIBITORS; PROTEINS; BALANCE;
D O I
10.1038/leu.2008.239
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:594 / 596
页数:4
相关论文
共 50 条
  • [1] Noxa upregulation is associated with apoptosis of chronic lymphocytic leukemia cells induced by hyperforin but not flavopiridol
    M Zaher
    I Akrout
    M Mirshahi
    J-P Kolb
    C Billard
    Leukemia, 2009, 23 : 594 - 596
  • [2] Hyperforin induces apoptosis of chronic lymphocytic leukemia cells through upregulation of the BH3-only protein Noxa
    Zaher, Murhaf
    Tang, Ruoping
    Bombarda, Isabelle
    Merhi, Faten
    Bauvois, Brigitte
    Billard, Christian
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (01) : 269 - 276
  • [3] Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells
    Baou, Maria
    Kohlhaas, Susan L.
    Butterworth, Michael
    Vogler, Meike
    Dinsdale, David
    Walewska, Renata
    Majid, Aneela
    Eldering, Eric
    Dyer, Martin J. S.
    Cohen, Gerald M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (09): : 1510 - 1518
  • [4] Flavopiridol-induced iNOS downregulation during apoptosis of chronic lymphocytic leukemia cells is caspase-dependent
    Billard, Christian
    Menasria, Faouzia
    Quiney, Claire
    Faussat, Anne-Marie
    Kolb, Jean-Pierre
    LEUKEMIA RESEARCH, 2008, 32 (05) : 755 - 760
  • [5] ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia
    Tonino, S. H.
    van Laar, J.
    van Oers, M. H.
    Wang, J. Y.
    Eldering, E.
    Kater, A. P.
    ONCOGENE, 2011, 30 (06) : 701 - 713
  • [6] ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia
    S H Tonino
    J van Laar
    M H van Oers
    J Y Wang
    E Eldering
    A P Kater
    Oncogene, 2011, 30 : 701 - 713
  • [7] Flavopiridol in the treatment of chronic lymphocytic leukemia
    Christian, Beth A.
    Grever, Michael R.
    Byrd, John C.
    Lin, Thomas S.
    CURRENT OPINION IN ONCOLOGY, 2007, 19 (06) : 573 - 578
  • [8] Chronic lymphocytic leukemia: A niche for flavopiridol?
    Brown, JR
    CLINICAL CANCER RESEARCH, 2005, 11 (11) : 3971 - 3973
  • [9] Flavopiridol in Chronic Lymphocytic Leukemia: A Concise Review
    Christian, Beth A.
    Grever, Michael R.
    Byrd, John C.
    Lin, Thomas S.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S179 - S185
  • [10] Alvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia
    Wiernik, Peter H.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (06) : 729 - 734